Back to Market Feed

Historical record - last NADAC effective date: 1/17/2024

Product Information

VALACYCLOVIR HCL 1 GRAM TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.5109 per EA under NDC 59746032537. Its NADAC has been published 532 times since Nov 28, 2013.

FDA first approved this application on Apr 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALACYCLOVIR HCL 1 GRAM TABLET

valacyclovir hydrochloride
$0.5109per EA

Strength

1 g/1

NDC

59746032537

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

1/17/2024

Active Ingredients

VALACYCLOVIR HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA201506

FDA Approved

4/3/2012

TE Code

AB

On Market Since

4/5/2012

Pharmacological Classes

DNA Polymerase Inhibitors
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Nucleoside Analog

Price Statistics

The NADAC for VALACYCLOVIR HCL 1 GRAM TABLET has been published 532 times since Nov 28, 2013, and over the history we have for it it has declined 59.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5109 per EA
All-time high$1.5320 (Feb 12, 2014)
All-time low$0.4600 (Jan 18, 2023)
Median price$0.5563
Average price$0.6551
Largest weekly change-21.0% (Aug 19, 2015)
Weeks tracked532
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+5.9%

5Y

-22.1%

All

-59.2%

Last surveyed Jan 31, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 20%

2 alternatives • Same active ingredient

VALACYCLOVIR HCL 1 GRAM TABLET
Generic
59746032590•Jubilant Cadista Pharmaceuticals Inc.
$0.4072
Save 20%
VALTREX 1 GRAM CAPLET
Brand
00173056510•GlaxoSmithKline LLC
$20.2440
+3863% more

Related Drugs

Same classification

ACYCLOVIR 200 MG/5 ML SUSP
Generic
00472008216•Actavis Pharma, Inc.
$0.0764
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
31722068147•Camber Pharmaceuticals Inc.
$0.0764
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
62135080347•Chartwell RX LLC
$0.0764
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
70954018810•ANI Pharmaceuticals, Inc.
$0.0764
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72205017072•Novadoz Pharmaceuticals LLC
$0.0764
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72888007917•Advagen Pharma Ltd.
$0.0764
per ML
ACYCLOVIR 400 MG TABLET
Generic
75834012201•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 400 MG TABLET
Generic
75834012205•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 400 MG TABLET
Generic
00904750761•Major Pharmaceuticals
$0.0962
per EA
ACYCLOVIR 400 MG TABLET
Generic
23155022701•Heritage Pharmaceuticals Inc.
$0.0962
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Jubilant Cadista Pharmaceuticals Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

valacyclovir hydrochloride market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of VALACYCLOVIR HCL 1 GRAM TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VALACYCLOVIR HCL 1 GRAM TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.5109 per EA (NDC 59746032537), effective Jan 31, 2024.

How has the price of VALACYCLOVIR HCL 1 GRAM TABLET changed over time?

Over the history we have for it, the NADAC for VALACYCLOVIR HCL 1 GRAM TABLET has declined 59.2%. It has been tracked across 532 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VALACYCLOVIR HCL 1 GRAM TABLET?

Since Nov 28, 2013, the NADAC for VALACYCLOVIR HCL 1 GRAM TABLET has ranged from a low of $0.4600 (Jan 18, 2023) to a high of $1.5320 (Feb 12, 2014), with a median of $0.5563 per EA.

Are there cheaper alternatives to VALACYCLOVIR HCL 1 GRAM TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALACYCLOVIR HCL 1 GRAM TABLET, is $0.4072 per EA — about 20% below VALACYCLOVIR HCL 1 GRAM TABLET.

Who manufactures VALACYCLOVIR HCL 1 GRAM TABLET?

VALACYCLOVIR HCL 1 GRAM TABLET (NDC 59746032537) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.